112 related articles for article (PubMed ID: 3242091)
1. [Possible immunologic prevention of recurrences and metastases of gastric cancer after its radical surgical treatment].
Ageenko AI; Drakina LV; Kogan IIa; Vitogran IuE; Babaian LA
Sov Med; 1988; (10):27-30. PubMed ID: 3242091
[No Abstract] [Full Text] [Related]
2. [Combined treatment of cancer of the stomach using a specific immunotherapy].
Chissov VI; Ageenko AI; Vashakmadze LA; Babaian LA; Shcherbitskaia IIa; Drakina LV; Zubova IuE
Sov Med; 1991; (8):30-2. PubMed ID: 1763356
[TBL] [Abstract][Full Text] [Related]
3. Treatment with 5-fluorouracil in prophylaxis of relapses and metastases of stomach cancer.
Blokhina NG; Garin AM; Moroz LV; Pershin MP; Chumakina SI; Gunka II; Pantophel AM; Steklenev NA; Zirin MA; Grjaznova IN; Shain AA; Pecherskaja BG; Saveliev NP; Bashirova NG; Kuzmin VP; Budarina EM; Svedencov EP; Phateeva KV; Iunusmetov IR; Silitrin NP; Shklovskii GS; Balas AN; Ushivceva AE
Neoplasma; 1972; 19(4):351-6. PubMed ID: 5054535
[No Abstract] [Full Text] [Related]
4. [Recurrences after surgical treatment of early (pT1) cancer of the stomach: laws of development, extended lymphadenectomy in prophylaxis of recurrences].
Skoropad VIu; Berdov BA
Khirurgiia (Mosk); 2007; (1):43-8. PubMed ID: 17426689
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary results of the use of 5-fluoruracil to prevent recurrences and metastases following radical surgery for stomach cancer].
Blokhina NG; Garin AM; Voznyĭ EK; Moroz LV; Karev NI
Vestn Akad Med Nauk SSSR; 1972; 27(10):29-36. PubMed ID: 4641119
[No Abstract] [Full Text] [Related]
6. [Studies on the prevention of recurrence after surgical removal of tumors].
Yamamoto T; Ijima N; Kato I; Matsuzawa A
Iryo; 1967 Jan; 21(1):48-54. PubMed ID: 6037007
[No Abstract] [Full Text] [Related]
7. [Evaluation of the effectiveness of radical surgical treatment in stomach cancer].
Kustov VI
Vopr Onkol; 1981; 27(4):90-4. PubMed ID: 7233882
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical results of application of antitumor vaccines obtained by means of bacterial metabolism.
Zatula DG
Neoplasma; 1984; 31(1):65-74. PubMed ID: 6422316
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
[TBL] [Abstract][Full Text] [Related]
10. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer.
Wu CW; Lo SS; Shen KH; Hsieh MC; Chen JH; Chiang JH; Lin HJ; Li AF; Lui WY
World J Surg; 2003 Feb; 27(2):153-8. PubMed ID: 12616428
[TBL] [Abstract][Full Text] [Related]
11. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
12. [Determination of the risk period for development of recurrences and metastases of stomach cancer].
Simonov NN
Sov Med; 1977 Feb; (2):100-4. PubMed ID: 854768
[No Abstract] [Full Text] [Related]
13. [On the advisability of repeated control laparotomies after stomach resection for cancer].
Samokhvalov VI
Vopr Onkol; 1966; 12(3):75-8. PubMed ID: 5991966
[No Abstract] [Full Text] [Related]
14. [Surgical experience of cancer of the resected stomach].
Slizzow V; Marx G; Seifart V
Vopr Onkol; 1983; 29(6):23-7. PubMed ID: 6191439
[TBL] [Abstract][Full Text] [Related]
15. [Value of consistent after care in stomach cancer].
Wenzl E; Feil W; Schiessel R
Wien Klin Wochenschr; 1987 Jun; 99(12):420-3. PubMed ID: 3617770
[TBL] [Abstract][Full Text] [Related]
16. [Regularities of relapse and metastasis of signet ring cell carcinoma of the stomach following combined and surgical treatment].
Skoronad VIu; Berdov BA; Loktionova OV
Vopr Onkol; 2007; 53(5):538-43. PubMed ID: 18154117
[TBL] [Abstract][Full Text] [Related]
17. [Surgical management of locoregional recurrence of gastric carcinoma].
Hoksch B; Müller JM
Zentralbl Chir; 1999; 124(12):1087-90. PubMed ID: 10670093
[TBL] [Abstract][Full Text] [Related]
18. Pathological features as predictors of recurrence after radical resection of gastric cancer.
Buzzoni R; Bajetta E; Di Bartolomeo M; Miceli R; Beretta E; Ferrario E; Mariani L
Br J Surg; 2006 Feb; 93(2):205-9. PubMed ID: 16363019
[TBL] [Abstract][Full Text] [Related]
19. Recurrence in patients following curative resection of early gastric carcinoma.
Wu B; Wu D; Wang M; Wang G
J Surg Oncol; 2008 Nov; 98(6):411-4. PubMed ID: 18767119
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment of multivisceral intra-abdominal recurrences and metastases].
Servatius HG; Ernst R; Krugmann M; Rembs E; Zumtobel V
Ann Chir; 1993; 47(1):52-7. PubMed ID: 8498786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
